Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 1
2006 1
2007 1
2008 3
2009 3
2010 4
2011 2
2012 3
2013 6
2014 10
2015 10
2016 7
2017 9
2018 11
2019 11
2020 8
2021 11
2022 7
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Results by year

Filters applied: . Clear all
Page 1
S2k-Leitlinie zur Therapie des Pemphigus vulgaris/foliaceus und des bullösen Pemphigoids: 2019 Update.
Schmidt E, Sticherling M, Sárdy M, Eming R, Goebeler M, Hertl M, Hofmann SC, Hunzelmann N, Kern JS, Kramer H, Nast A, Orzechowski HD, Pfeiffer C, Schuster V, Sitaru C, Zidane M, Zillikens D, Worm M. Schmidt E, et al. Among authors: kern js. J Dtsch Dermatol Ges. 2020 May;18(5):516-527. doi: 10.1111/ddg.14097_g. J Dtsch Dermatol Ges. 2020. PMID: 32413222 German. No abstract available.
Calciphylaxis.
Zhou Q, Neubauer J, Kern JS, Grotz W, Walz G, Huber TB. Zhou Q, et al. Among authors: kern js. Lancet. 2014 Mar 22;383(9922):1067. doi: 10.1016/S0140-6736(14)60235-X. Epub 2014 Feb 28. Lancet. 2014. PMID: 24582472 No abstract available.
Basics of immunohistochemistry.
Schacht V, Kern JS. Schacht V, et al. Among authors: kern js. J Invest Dermatol. 2015 Mar;135(3):1-4. doi: 10.1038/jid.2014.541. J Invest Dermatol. 2015. PMID: 25666678 Free article. No abstract available.
Bläulich-graue Pigmentierung.
Anthony E, Arnold AW, Kern JS. Anthony E, et al. Among authors: kern js. J Dtsch Dermatol Ges. 2018 Sep;16(9):1149-1151. doi: 10.1111/ddg.13635_g. J Dtsch Dermatol Ges. 2018. PMID: 30179339 No abstract available.
Randomized controlled trial of omalizumab in treatment-resistant systemic and cutaneous mastocytosis (ROAM).
McComish JS, Slade CA, Buizen L, Paul SK, Chatelier JW, Unglik G, Nicholls KA, Spriggs K, Chan SS, Godsell J, Auyeung P, Tan ZH, DeLuca J, Patel M, Kuek LE, Tran Y, Kern JS, Scardamaglia L, Varigos GA, Juneja S, Grabek JA, Christie M, Mackay GA, Douglass JA. McComish JS, et al. Among authors: kern js. J Allergy Clin Immunol Pract. 2023 Jul;11(7):2248-2250.e3. doi: 10.1016/j.jaip.2023.04.008. Epub 2023 Apr 23. J Allergy Clin Immunol Pract. 2023. PMID: 37088371 Clinical Trial. No abstract available.
Bluish grey pigmentation.
Anthony E, Arnold AW, Kern JS. Anthony E, et al. Among authors: kern js. J Dtsch Dermatol Ges. 2018 Sep;16(9):1149-1151. doi: 10.1111/ddg.13635. Epub 2018 Aug 16. J Dtsch Dermatol Ges. 2018. PMID: 30112805 No abstract available.
Australian Teledermatology experience during COVID-19.
Low ZM, Scardamaglia L, Morgan V, Kern JS. Low ZM, et al. Among authors: kern js. Australas J Dermatol. 2021 Nov;62(4):e596-e600. doi: 10.1111/ajd.13681. Epub 2021 Aug 16. Australas J Dermatol. 2021. PMID: 34398453 Free PMC article. No abstract available.
CXCL17 induces activation of human mast cells via MRGPRX2.
Ding J, Hillig C, White CW, Fernandopulle NA, Anderton H, Kern JS, Menden MP, Mackay GA. Ding J, et al. Among authors: kern js. Allergy. 2024 Jan 26. doi: 10.1111/all.16036. Online ahead of print. Allergy. 2024. PMID: 38279626 No abstract available.
99 results